Korean journal of dermatology (대한피부과학회지)

Korean Dermatological Association (대한피부과학회)
권호 표지

A Study on Quality of Life and Economic Burden in Korean Patients with Atopic Dermatitis and Their Parents

아토피피부염 환자의 삶의 질과 경제적 부담에 관한 연구

Kim, Eun-Jung;Kim, Hyung-Ok;Park, Young-Min
김은정;김형옥;박영민

  • Published : 20080000
⟨ Previous Next ⟩

Abstract

Background: Because of the chronic course and highly disfigured skin lesions, atopic dermatitis (AD) has a substantial impact on quality of life (QoL). Moreover, previous studies assessing the financial cost of AD have shown that it represents a notable economic burden. However, data about QoL and the economic burden on Korean patients with AD are limited. Objective: The purpose of this study is to assess the impact of AD on QoL as well as the economic burden in Korean patients and their parents. Methods: A questionnaire specifically designed by our clinical experience was used to determine the ways in which AD affects the lives of the patients and/or their parents. Eighty-two patients and 47 parents completed the self-administrated questionnaires, including the questions on multi-dimensional aspects of QoL. They were also surveyed to find how much money they have spent in the treatment of AD during the last 6 months. In addition, for each patient the disease severity was evaluated by using the SCORAD index. Results: The QoL data revealed that AD had significantly negative effects on QoL through all aspects of life including daily living activities (37.2), psychological status (30.0) and social functioning (23.7). The QoL scores significantly increase in proportion to the increasing severity of AD (p＜0.0001). With regard to daily living activities, a major stress-causing factor was restriction on cosmetic use (50.0). For psychological status, 91.5% of patients reported that they feel deeply nervous about the likelihood of their offspring having AD in future (62.2). Regarding social functioning, it was told that AD patients had difficulties in developing relationships (28.8). AD parents also had high level of stress associated with modifying lifestyles (42.1). The estimated cost related to AD has the positive correlation with the severity of AD. Of importance, the average direct medical cost corresponds to only 29% of the total cost, while the indirect cost represents 71% of the total cost. Conclusion: These results demonstrate that AD has a significant impact on the various components of QoL in Korean patients and their parents. Moreover, AD imposes a considerable economic burden on the family budget. (Korean J Dermatol 2008;46(2):160∼170)

Keywords

References

  1. Leung YMD, Eichenfield LF, Boguniewicz M. Atopic dermatitis, In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editors. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2003:1180-1194
  2. Finlay AY. Quality of life in atopic dermatitis. J Am Acad Dermatol 2001;45:S64-S66 https://doi.org/10.1067/mjd.2001.117010
  3. Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006;60:984-992 https://doi.org/10.1111/j.1742-1241.2006.01047.x
  4. Feldman S, Behnam SM, Behnam SE, Koo JYM. Involving the patient: impact of inflammatory skin disease and patient-focused care. J Am Acad Dermatol 2005;53:S78-S85 https://doi.org/10.1016/j.jaad.2005.04.033
  5. Ricci G, Bendandi B, Paglira L, Patrizi A, Masi M. Atopic dermatitis in Italian children: evaluation of its economic impact. J Pediatr Health Care 2006;20:311-315 https://doi.org/10.1016/j.pedhc.2006.04.009
  6. Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB, Manuel JC. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 2005;22:192-199 https://doi.org/10.1111/j.1525-1470.2005.22303.x
  7. Jenner N, Campbell J, Marks R. Morbidity and cost of atopic eczema in Australia. Australas J Dermatol 2004;45:16-22 https://doi.org/10.1111/j.1440-0960.2004.00046.x
  8. Verboom P, Roijen LH, Sturkenboom M, Zeeuw RD, Menke H, Rutten F. The cost of atopic dermatitis in the Netherlands: an international comparison. Br J Dermatol 2002;147:716-724 https://doi.org/10.1046/j.1365-2133.2002.04964.x
  9. Barbeau M, Lalonde H. Burden of atopic dermatitis in Canada. Int J Deramtol 2006;45:31-36 https://doi.org/10.1111/j.1365-4632.2004.02345.x
  10. Emerson RM, Williams HC, Allen BR. The financial impact on families of children with atopic dermatitis. Br J Dermatol 2001;143:514-522
  11. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980;92(Suppl):44-47
  12. Whalley D, McKenna SP, Dewar AL, Erdman RA, Kohlmann T, Niero M, et al. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol 2004;150:274-283 https://doi.org/10.1111/j.1365-2133.2004.05783.x
  13. McKenna SP, Walley D, Dewar AL, Erdman RA, Kohlmann T, Niero M, et al. International development of the parent's Index of Quality of Life in Atopic Dermatitis (PIQoL-AD). Qual Life Res 2005;14:231-241 https://doi.org/10.1007/s11136-004-4231-z
  14. Kwon JA, Roh KY, Koh BK, Kim JW. Clinical characteristics of adolescence and adult atopic dermatitis in Korea. Korean J Dermatol 2004;42:949-954
  15. Park YM, Byun DG, Kim JW. Evaluation of minor clinical features of adolescence and adult atopic dermatitis in Korea. Korean J Dermatol 1994;32:1046-1053
  16. Park YM, Park HJ, Kim TY, Kim CW. The study on the hospital-based relative frequency, and clinical and laboratory findings of atopic dermatitis. Korean J Dermatol 1997;35:96-106
  17. Dahl RE, Bernhisel-Broadbent J, Scanlon-Holdfor S, Samson HA, Lupo M. Sleep disturbances in children with atopic dermatitis. Arch Pediatr Adolesc Med 1995;149:856-860 https://doi.org/10.1001/archpedi.1995.02170210030005
  18. Al-Ahmar HF, Kurban A. Psychological profile with atopic dermatitis. Br J Dermatol 1976;95:373-377 https://doi.org/10.1111/j.1365-2133.1976.tb00838.x
  19. Ginsburg IH, Prystowsky JH, Kornfeld DS, Wolland H. Role of emotional factors in adults with atopic dermatitis. Int J Dermatol 1993;32:656-660 https://doi.org/10.1111/j.1365-4362.1993.tb04021.x
  20. Holm EA, Esmann S, Jemec GBE. The handicap caused by atopic dermatitis - sick leave and job avoidance. J Eur Acad Dermatol Venereol 2006;20:255-259 https://doi.org/10.1111/j.1468-3083.2006.01416.x
  21. Su JC, Kenp AS, Varigos GA, Nolan TM. Atopic eczema: its impact on the family and financial cost. Arch Dis Child 1997;76:159-162 https://doi.org/10.1136/adc.76.2.159
  22. Lapidus CS, Kerr PE. Social impact of atopic dermatitis. Med Health R I 2001;84:294-295
  23. Barsa MKA, Finlay, AY. The family impact of skin disease: the greater patient concept. Br J Dermatol 2007;156:929-937 https://doi.org/10.1111/j.1365-2133.2007.07794.x
  24. Shin N, Kim S, Cho S, Whang K, Halm J. The impact of childhood atopic dermatitis on their families. Korean J Dermatol 2000;38:494-499
  25. Hon KI, Kam WY, Lam MC, Leung TF. CDLQI, SCORAD and NESS: are they correlated? Qual Life Res 2006;15:1551-1558 https://doi.org/10.1007/s11136-006-0019-7
  26. Ben-Gashir MA, Seed PT, Hay RJ. Quality of life and disease severity are correlated in children with atopic dermaititis. Br J Dermatol 2004;150:284-290 https://doi.org/10.1111/j.1365-2133.2004.05776.x
  27. Balkrishnan R, Housman TS, Carroll C, Feldman SR, Fleischer AB. Disease severity and associated family impact in childhood atopic dermatitis. Arch Dis Child 2003;88:423-427 https://doi.org/10.1136/adc.88.5.423
  28. Kemp AS. Cost of illness of atopic dermatitis in children: a societal perspective. Pharmacoeconomics 2003;21:105-113 https://doi.org/10.2165/00019053-200321020-00003
  29. Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel R, et al. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol 2002;46:361-370 https://doi.org/10.1067/mjd.2002.120528
  30. Fivenson D, Arnold RJ, Kaniecki DJ, Cohen JL, Frech F, Finlay AY. The effect of atopic dermatitis on total burden of life on adults and children in a large managed care organization. J Manag Care Pharm 2002;8:333-342 https://doi.org/10.18553/jmcp.2002.8.5.333
  31. Chin HW, Jang HS, Jang BS, Jo JH, Kim MB, Oh CK, et al. A study on utilization of alternative medicine for patients with atopic dermatitis. Korean J Dermatol 2005;43:903-911
  32. Johnston GA, Bilbao RM, Graham-Brown RA. The use of complementary medicine in children with atopic dermatitis in secondary care in Leicester. Br J Dermatol 2003;149:566-571 https://doi.org/10.1046/j.1365-2133.2003.05471.x